AIM ImmunoTech Announces First COVID-19-Induced Chronic Fatigue “Long Hauler” Patient Dosed with Ampligen
AIM ImmunoTech Announces First COVID-19-Induced Chronic Fatigue “Long Hauler” Patient Dosed with Ampligen
OCALA, Fla., Jan. 06, 2021 AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the active AMP-511 Expanded Access Program (EAP) has dosed its first COVID-19 “Long Hauler” patient with the drug Ampligen (rintatolimod), marking a significant milestone in AIM’s efforts to develop an effective therapeutic for people suffering from post-COVID-19 infection chronic fatigue-like symptoms. Additional patients are in the process of being enrolled. The Company also reported it will host an investor conference call on January 12, 2020 at 11AM ET to discuss the AMP-511 trial, believed to be the first clinical trial to treat a patient with COVID-19-induced chronic fatigue-like symptoms, as well as to provide an overall status update on the Company.
Biden to Release More Doses: Virus Update Bloomberg 1/8/2021 Bloomberg News
(Bloomberg) President-elect Joe Biden says he’ll distribute more of the available doses of coronavirus vaccines, as the U.S. surpassed 4,000 daily fatalities for the first time. New York City has 270,000 unused vaccine doses that it’s seeking to administer to residents over age 75, Mayor Bill de Blasio said. Maine broke records for infections and deaths.
London’s mayor declared an emergency as the U.K. reported record fatalities. Germany also reported the most daily deaths since the start of the pandemic.
As the U.K. approved the Moderna Inc. vaccine for emergency use, the European Union secured an extra 300 million doses of the Pfizer Inc.-BioNTech SE shot. Iran banned U.S. and U.K. vaccinations.
Image by National Institutes of Allergy and Infectious Diseases
UC San Francisco scientists have discovered a new way to control the immune systemâs ânatural killerâ (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The findings could also be used to enhance the ability of cancer immunotherapies to detect and destroy lurking tumors.Â
The study, published Jan. 8, 2021, in the
Journal of Experimental Medicine, addresses a major challenge for the field of regenerative medicine, said lead author Tobias Deuse, MD, the Julien I.E. Hoffman, MD, Endowed Chair in Cardiac Surgery in the UCSF Department of Surgery.Â
Biden to Release More Doses: Virus Update Bloomberg 1/8/2021 Bloomberg News
(Bloomberg) President-elect Joe Biden says he’ll distribute more of the available doses of coronavirus vaccines, as the U.S. surpassed 4,000 daily fatalities for the first time. New York City has 270,000 unused vaccine doses that it’s seeking to administer to residents over age 75, Mayor Bill de Blasio said. Maine broke records for infections and deaths.
London’s mayor declared an emergency as the U.K. reported record fatalities. Germany also reported the most daily deaths since the start of the pandemic.
As the U.K. approved the Moderna Inc. vaccine for emergency use, the European Union secured an extra 300 million doses of the Pfizer Inc.-BioNTech SE shot. Iran banned U.S. and U.K. vaccinations.
Biden to Release More Doses: Virus Update Bloomberg 1/8/2021 Bloomberg News
(Bloomberg) President-elect Joe Biden says he’ll distribute more of the available doses of coronavirus vaccines, as the U.S. surpassed 4,000 daily fatalities for the first time. New York City has 270,000 unused vaccine doses that it’s seeking to administer to residents over age 75, Mayor Bill de Blasio said. Maine broke records for infections and deaths.
London’s mayor declared an emergency as the U.K. reported record fatalities. Germany also reported the most daily deaths since the start of the pandemic.
As the U.K. approved the Moderna Inc. vaccine for emergency use, the European Union secured an extra 300 million doses of the Pfizer Inc.-BioNTech SE shot. Iran banned U.S. and U.K. vaccinations.